United States

Aspen Neuroscience, Inc. (ASPE)

Aspen Neuroscience recorded four significant buy transactions totaling approximately 38 million dollars on November 2, 2026. These acquisitions were executed exclusively by institutional entities, specifically ARCH Venture Fund X and ARCH Venture Partners XIV. No executive selling activity occurred during this period, despite a 13.1 percent decline in share price over the preceding ninety days.
Ticker: ASPE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Thompson Peter A. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
418.81
Quantity 21,823 -5.6%
Value US$1,442,828
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
73.49
Quantity 18,394 -37.8%
Value US$1,286,311
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-04 2026-11-02 B Purchase
3.0
Thompson Peter A.
Non-Executive Director Large shareholder
21,823 -5.6%
418.81
US$1,442,828 		21,823 -5.6% 418.81 US$1,442,828
2026-11-04 2026-11-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
18,394 -37.8%
73.49
US$1,286,311 		18,394 -37.8% 73.49 US$1,286,311
2026-11-02 2026-11-02 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
13,956 -7.8%
468.71
US$3,059,731 		13,956 -7.8% 468.71 US$3,059,731
2026-11-02 2026-11-02 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
1,000 New position
15.00
US$100,000 		1,000 New position 15.00 US$100,000
2026-11-02 2026-11-02 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
1,000 New position
15.00
US$100,000 		1,000 New position 15.00 US$100,000
2026-11-02 2026-11-02 B Purchase
ARCH Venture Partners XIV, L.P.
Large shareholder
1,000 New position
15.00
US$100,000 		1,000 New position 15.00 US$100,000
Explore more

More insider trading research around Aspen Neuroscience, Inc.

More insider trades in United States
Insider trading in North America